July 10, 2012
A new report on ADR (adverse drug reaction) made by Pharmacosmos
shows an industry-low number of reported ADRs.
"In 12 years, Pharmacosmos has a reporting rate of ADRs of less
than 0.00005%" says Lars Lykke Thomsen, Vice President & Chief
Medical Officer .
This has to be measured up against the fact that Uniferon is now
available in numerous countries around the world and is considered
the injectable iron market leader.
"At Pharmacosmos, we take deep pride in our excellent track
record, and we work diligently to maintain a high level of quality
in all aspects concerning the product" says Lars Christensen,
President & Chief Executive Officer.
Have a look at the journey behind each batch of Uniferon in the
interactive Life
Cycle animation here - and learn firsthand why safety comes
from quality.
About Uniferon
Uniferon is a modern improved iron hydrogenated dextran based on
a natural formula, which is approved for global use:
Uniferon is manufactured without the use of any organic solvents
or cyanide, thus, avoiding trace residues of these impurities.
Pharmacosmos manufactures iron dextran of high quality and unique
purity for customers worldwide. Uniferon is the only injectable
iron brand for piglets approved in the EU, the US and Asia.
About Pharmacosmos
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.